Previous close | 3.0000 |
Open | 3.9000 |
Bid | 3.5000 |
Ask | 5.6000 |
Strike | 17.50 |
Expiry date | 2024-10-18 |
Day's range | 3.8700 - 3.9800 |
Contract range | N/A |
Volume | |
Open interest | 74 |
JERSEY CITY, N.J., May 07, 2024--Organon (NYSE: OGN) ("Organon"), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the "Co-Issuer" and, together with Organon, the "Companies"), plan to offer, subject to market conditions, $500 million of senior secured notes due 2034 (the "secured notes") and $500 million of senior unsecured notes due 2034 (the "unsecu
The board of Organon & Co. ( NYSE:OGN ) has announced that it will pay a dividend on the 13th of June, with investors...
Organon ( NYSE:OGN ) First Quarter 2024 Results Key Financial Results Revenue: US$1.62b (up 5.5% from 1Q 2023). Net...